RAI14 and glioblastoma: Shen et al. reported that the inhibition of the mammalian target of the rapamycin pathway decreases RAI14 and IL-6 in the U87 glioblastoma cell line, and this suggests that there is a relationship between RAI14 and inflammation [9].